These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 198404)

  • 1. Mast cell binding of neurotensin. II. Molecular conformation of neurotensin involved in the stereospecific binding to mast cell receptor sites.
    Lazarus LH; Perrin MH; Brown MR; Rivier JE
    J Biol Chem; 1977 Oct; 252(20):7180-3. PubMed ID: 198404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity and conformational studies of a series of modified C-terminal hexapeptide neurotensin analogues.
    Heyl DL; Sefler AM; He JX; Sawyer TK; Wustrow DJ; Akunne HC; Davis MD; Pugsley TA; Heffner TG; Corbin AE
    Int J Pept Protein Res; 1994 Sep; 44(3):233-8. PubMed ID: 7822099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible conformations involved in the binding of neurotensin, xenopsin and bradykinin molecules to mast cell receptors.
    Podinsh LU; Betinsh YaR ; Nikiforovich GV; Chipens GI
    FEBS Lett; 1983 Mar; 153(1):25-8. PubMed ID: 6825862
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological characterization of neurotensin receptors in the rat isolated portal vein using analogues and fragments of neurotensin.
    Rioux F; Quirion R; Regoli D; Leblanc MA; St-Pierre S
    Eur J Pharmacol; 1980 Sep; 66(4):273-9. PubMed ID: 6252013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cell binding of neurotensin. I. Iodination of neurotensin and characterization of the interaction of neurotensin with mast cell receptor sites.
    Lazarus LH; Perrin MH; Brown MR
    J Biol Chem; 1977 Oct; 252(20):7174-9. PubMed ID: 20445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of neurotensin with the substance P receptor mediating histamine release from rat mast cells and the flare in human skin.
    Foreman JC; Jordan CC; Piotrowski W
    Br J Pharmacol; 1982 Nov; 77(3):531-9. PubMed ID: 6182939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotensin analogues. Structure--activity relationships.
    Rivier JE; Lazarus LH; Perrin MH; Brown MR
    J Med Chem; 1977 Nov; 20(11):1409-12. PubMed ID: 915901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine release by neurotensin in the rat hindquarter: structure-activity studies.
    Kerouac R; St-Pierre S; Rioux F
    Peptides; 1984; 5(4):695-9. PubMed ID: 6208534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity studies with neurotensin: analysis of positions 9, 10 and 11.
    Quirion R; Regoli D; Rioux F; St-Pierre S
    Br J Pharmacol; 1980 Aug; 69(4):689-92. PubMed ID: 7437646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced peptide bond pseudopeptide analogues of neurotensin.
    Doulut S; Rodriguez M; Lugrin D; Vecchini F; Kitabgi P; Aumelas A; Martinez J
    Pept Res; 1992; 5(1):30-8. PubMed ID: 1623301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposed ligand binding site of the transmembrane receptor for neurotensin(8-13).
    Pang YP; Cusack B; Groshan K; Richelson E
    J Biol Chem; 1996 Jun; 271(25):15060-8. PubMed ID: 8663052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity receptor sites and rapid proteolytic inactivation of neurotensin in primary cultured neurons.
    Checler F; Mazella J; Kitabgi P; Vincent JP
    J Neurochem; 1986 Dec; 47(6):1742-8. PubMed ID: 3021902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of the neurotensin8-13 analogs Asp13-NT8-13 and Asp12-NT8-13 on mast cell secretion.
    Miller LA; Cochrane DE; Carraway RE; Feldberg RS
    Agents Actions; 1993 Jan; 38(1-2):1-7. PubMed ID: 7683173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid degradation of neurotensin by stimulated rat mast cells.
    Cochrane DE; Carraway RE; Boucher W; Feldberg RS
    Peptides; 1991; 12(6):1187-94. PubMed ID: 1726119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of neurotensin by rat brain synaptic membranes: involvement of a thermolysin-like metalloendopeptidase (enkephalinase), angiotensin-converting enzyme, and other unidentified peptidases.
    Checler F; Vincent JP; Kitabgi P
    J Neurochem; 1983 Aug; 41(2):375-84. PubMed ID: 6308159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of neurotensin by rabbit brain endo-oligopeptidase A and endo-oligopeptidase B (proline-endopeptidase).
    Camargo AC; Caldo H; Emson PC
    Biochem Biophys Res Commun; 1983 Nov; 116(3):1151-9. PubMed ID: 6316969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topography of the neurotensin (NT)(8-9) binding site of human NT receptor-1 probed with NT(8-13) analogs.
    Lundquist JT; Büllesbach EE; Golden PL; Dix TA
    J Pept Res; 2002 Feb; 59(2):55-61. PubMed ID: 11906607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LANT-6, xenopsin and neuromedin N stimulate cyclic GMP at neurotensin receptors.
    Gilbert JA; Richelson E
    Eur J Pharmacol; 1986 Oct; 129(3):379-83. PubMed ID: 3023108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between structure and duration of neurotensin's central action: emergence of long acting analogs.
    Jolicoeur FB; St-Pierre S; Aubé C; Rivest R; Gagné MA
    Neuropeptides; 1984 Nov; 4(6):467-76. PubMed ID: 6514148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotensin analogs [D-TYR11] and [D-PHE11]neurotensin resist degradation by brain peptidases in vitro and in vivo.
    Checler F; Vincent JP; Kitabgi P
    J Pharmacol Exp Ther; 1983 Dec; 227(3):743-8. PubMed ID: 6361231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.